Related Experiment Video
Updated: Feb 3, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.5K
Potential new targets for drug development in severe asthma
Linda Zhu1,2, Christina E Ciaccio2,3, Thomas B Casale4
11Department of Internal Medicine, The University of Chicago, Chicago, IL USA.
The World Allergy Organization Journal
|November 3, 2018
Summary
New biologic therapies target specific immune pathways in severe asthma. These treatments focus on distinct asthma phenotypes, offering improved control and quality of life for patients.
Area of Science:
- Immunology
- Pulmonology
- Pharmacology
Background:
- Asthma treatment is increasingly recognizing distinct phenotypes impacting therapeutic responses.
- Biological therapies targeting specific immune cells and cytokines are emerging.
- Two primary asthma phenotypes, Type 2 high and Type 2 low, are defined by inflammatory patterns.
Purpose of the Study:
- To review the role of specific molecules in the inflammatory response of uncontrolled asthma.
- To discuss emerging biologic therapies targeting these molecules.
- To highlight the potential of targeted biologics for improving asthma control.
Main Methods:
- Literature review of current research on asthma phenotypes and biologic therapies.
- Analysis of immunological mechanisms in severe asthma.
- Discussion of novel drug targets and their associated emerging biologics.
Main Results:
- Most current biologics target Type 2 high asthma, including omalizumab, mepolizumab, reslizumab, and benralizumab.
- Investigational targets include IL-13, IL-4α receptor, CRTH2, TSLP, IL-25, IL-17A receptor, and CXCR2/IL-8.
- Delineation of distinct immunological mechanisms in severe asthma is crucial for targeted therapy.
Conclusions:
- Targeted biologic therapies hold significant promise for managing uncontrolled asthma.
- Understanding specific immunological pathways can lead to improved asthma control and patient quality of life.
- Emerging biologics offer new hope for patients with severe, refractory asthma.
Related Concept Videos
01:29Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
01:26Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.3K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.3K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K